HLS Therapeutics Inc. (HLS.TO)
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
|
Purchases
|
0 | 0 |
|
Sales
|
-- | 0 |
|
Net Shares Purchased (Sold)
|
0 | 0 |
|
Total Insider Shares Held
|
172.31k | -- |
|
% Net Shares Purchased (Sold)
|
-- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | 85,057 |
| % Change in Institutional Shares Held | 0.63% |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 3.22 per share. | Direct | 6,442 | Oct 30, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 30, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 3.25 per share. | Direct | 6,502 | Oct 29, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 29, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 3.23 per share. | Direct | 4,842 | Oct 28, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 28, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 3.27 per share. | Direct | 6,538 | Oct 27, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 27, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 3.18 per share. | Direct | 6,608 | Oct 26, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 26, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.95 per share. | Direct | 6,129 | Oct 23, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 23, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.95 per share. | Direct | 4,128 | Oct 22, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 22, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.95 per share. | Direct | 6,136 | Oct 21, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 21, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.94 per share. | Direct | 6,121 | Oct 20, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 20, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.92 per share. | Direct | 1,752 | Oct 19, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 19, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.94 per share. | Direct | 5,872 | Oct 16, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 16, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.92 per share. | Direct | 5,834 | Oct 15, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 15, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.90 per share. | Direct | 5,810 | Oct 14, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 14, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.89 per share. | Direct | 5,776 | Oct 13, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 13, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.97 per share. | Direct | 5,946 | Oct 9, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 9, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.98 per share. | Direct | 5,968 | Oct 8, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 8, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.98 per share. | Direct | 5,962 | Oct 7, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 7, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.96 per share. | Direct | 6,165 | Oct 6, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 6, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.78 per share. | Direct | 5,790 | Oct 5, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 5, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.80 per share. | Direct | 5,608 | Oct 2, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 2, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.88 per share. | Direct | 5,992 | Oct 1, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Oct 1, 2026 |
| Haroun (Daniel) Senior Officer of Issuer |
Acquisition in the public market at price 2.78 per share. | Direct | 5,558 | Sep 8, 2026 |
| Hanna, John Gordon Director of Issuer |
Acquisition in the public market at price 2.68 per share. | Direct | 5,366 | Sep 1, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.64 per share. | Direct | 5,284 | Aug 28, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Aug 28, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.66 per share. | Direct | 5,320 | Aug 27, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Aug 27, 2026 |
| HLS Therapeutics Inc. Issuer |
Redemption, retraction, cancelation, repurchase at price 2.70 per share. | Direct | 5,394 | Aug 26, 2026 |
| HLS Therapeutics Inc. Issuer |
-- | Direct | -- | Aug 26, 2026 |
